Table 1.
Demographic and clinical characteristics of CKD patients seen in control and intervention clinics during the study period
|
Variable |
Control clinic |
Intervention clinic |
P value |
|---|---|---|---|
| (n = 418) | (n = 363) | ||
| Age (years) |
71.0 (10.3) |
71.0 (10.7) |
0.99 |
| Gender (% male (N)) |
95.9% (401) |
94.5% (343) |
0.34 |
| Race (% black (N)) |
45.9% (192) |
44.9% (163) |
0.77 |
| Past Medical History (% (N)) |
|
|
|
| Diabetes |
50.2% (210) |
44.9% (163) |
0.14 |
| Hypertension |
93.1% (389) |
97.0% (352) |
0.013 |
| Coronary artery disease |
31.6% (132) |
40.8% (148) |
0.008 |
| Cancer |
21.1% (88) |
21.8% (79) |
0.81 |
| Last systolic BP (mmHg) |
133.1 (18.4) |
132.4 (17.9) |
0.63 |
| Last diastolic BP (mmHg) |
72.8 (11.7) |
71.6 (12.2) |
0.17 |
| Renal function |
|
|
|
| Average eGFR during study period* |
47.8 (40, 56) |
48.1 (39, 55) |
0.40 |
| Stage of CKD (%) |
|
|
|
| III |
91.6% |
89.5% |
0.52 |
| IV |
7.7% |
9.9% |
|
| V |
0.7% |
0.6% |
|
| Proteinuria |
24.2% |
20.7% |
0.24 |
| Most recent laboratory results |
|
|
|
| PTH* |
104 (61, 184) |
95 (62, 156) |
0.74 |
| Phosphorus |
3.7 (0.7) |
3.7 (0.7) |
0.54 |
| Hemoglobin |
12.8 (1.9) |
12.6 (1.8) |
0.35 |
| Number of clinic visits during study period |
2.4 (1.4) |
2.3 (1.4) |
0.30 |
| Seen by nephrology during the study period |
16.3% |
19.8% |
0.19 |
| Seen in urgent care during the study period | 49.8% | 52.9% | 0.38 |
* Median (25th, 75th percentile), Wilcoxon test.